Safety monitoring during the first month of the COVID-19 national vaccination program shows “reassuring safety profiles” for the Pfizer and Moderna COVID-19 vaccines, the Centers for Disease Control and Prevention reported today.

Emergency use authorizations for the vaccines require providers to report adverse events to the Vaccine Adverse Event Reporting System. About 91% of VAERS reports between Dec. 14, 2020, and Jan. 13, 2021, were for non-serious events and involved local and systemic symptoms, the authors said. Reported cases of anaphylaxis, a life-threatening but treatable allergic reaction, totaled 4.5 per million doses administered, comparable with those reported for other vaccines, they said.

The 113 deaths reported to VAERS over the period were consistent with expected all-cause mortality and did not suggest a causal relationship with vaccination, the authors said.

Related News Articles

Headline
President Biden yesterday continued the national emergency for the COVID-19 pandemic beyond March 1. The renewed national emergency, along with the recently…
Headline
The AHA and eight other hospital organizations today urged Senate leaders to include additional COVID-19 relief funding for health care providers in the…
Headline
The Food and Drug Administration's Office of Minority Health and Health Equity today released two videos on COVID-19 vaccines and the importance of communities…
Headline
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines,…
Headline
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective. According to the…
Headline
President Biden today will sign an executive order to create more resilient and secure supply chains for critical and essential goods, the White House…